SlideShare a Scribd company logo
YouScript
   Personalized Prescribing System from Genelex

        “Putting personalized medicine into practice”



Kristine Ashcraft, COO, Genelex
Copyright © 2011 Allscripts Healthcare Solutions, Inc.   1
Solution Overview
  YouScript® is the first and only clinical decision support tool that enables
   healthcare providers to consider cumulative multi-drug and gene interactions not
   covered by e-prescribing or EHR software interaction checking.
  YouScript integration with Allscript EHRs enables providers to consider the
   pharmacogenetic risk associated with a patient’s drug regimen at the point of care
   and to predict and prevent adverse drug events.
                • Assesses each providers’ patients to highlight those at high-risk, indicate
                  whether pharmacogenetic testing is suggested, and offer risk management options.
                • Once tested, the patient’s Personalized Prescribing Report and genotype will
                  be added to the patient’s profile.
                • Continues to monitor changes to the provider’s patient set, alerting the provider to
                  new risks, and reflecting the total interaction risk for the provider’s patient
                  population.

  YouScript helps reduce the practice’s overall ADE risk level and contributes to
   better outcomes.
  YouScript is the first real step towards putting personalized medicine into practice.

A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.               2
Solution Overview
  Healthcare/Business problem addressed:
         • Adverse drug events are the third leading cause of death in the U.S. and cost
           the nation $289 billion in unnecessary healthcare costs.
         • More than 75% of the population have genetic variations that change how
           they react to the majority of commonly prescribed medicines.
         • YouScript helps reduce adverse drug events by ensuring every patient receives
           the right medication for their unique genotype in the context of their current
           medication regimen. Ultimately, this helps physicians improve patient outcomes
           and satisfaction, reduce ER visits and hospitalizations, and save time in
           medication selection.
  The application developed addresses the following category:
          Applications that improve management of high cost chronic diseases.
          Innovative approaches to addressing value-based care imperatives.
          Both


A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.   3
Usability and Design
  YouScript leverages the tasking feature of Allscripts EHRs to prompt the provider to review high-
       risk patients on their schedule and consider pharmacogenetic testing when appropriate.
  Once tested, YouScript adds actionable alerts to the Provider’s task list requiring them to review
       and approve the patient’s personal prescribing report.
  YouScript aligns with the Allscript’s physician’s daily workflow by monitoring patient records for
       medication changes and prompting the provider to take action whenever a patient is placed at
       significant risk.
  YouScript’s actionable Interaction Reports allow the physician to explore implications of possible
       medication changes, and identify the safest alternatives for the patient prior to prescribing.
  YouScript empowers the provider to manage their practice’s overall risk level by providing
       dashboard views summarizing total population risk, and making concrete recommendations for
       next steps.




A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.              4
YouScript/Allscripts Workflow
 One Time

                         1                           Test High 2                                               3
                                                                                                 Review Test
                                                     PGX Risk                                                                            4
                                                                                                   Results                    Adjust
     Identify High                                    Patients
     Risk Patients                                                                                                          Medication
                                                       Drug Risk                                   Review                    Regimen
                                                         Only                                     YouScript



 Ongoing
                              5                                                              6                          7
                                                                    Monitor
                                                                                                       Alert Provider
          Drug Change                                               Change
                                                                                                       if Significant
                                                                    Impact




A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.
Development Stage
 Please indicate the development stage as of the Phase 1
     Submission Date:
        Idea
        Prototype
        Code development in progress
        Code complete
        Code complete, tested and approved by Allscripts.

       • UI design and development is complete. Allscripts integration
         development is 50% complete with code complete targeted at end of
         March for a May release date.




A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.   6
Integration Description
 Current implementation based on available Allscripts APIs
  include:
               • Patient Demographic Data for the provider to view through YouScript.

               • Patient Medication Lists are extracted into YouScript.

               • YouScript inserts tasks into the provider task list

               • YouScript inserts new documents as a lab result and attaches them to a task.

               • YouScript updates patient record with genotype test results

 Proposed additional features requiring new Allscripts APIs:
               • Real-time alert of ADE risk increases when medication changes are made




A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.      7
Integration Description
 APIs/Web Services calls include:
       •    GetPatient
       •    GetPatientSections
       •    GetSchedule
       •    SearchPatient
       •    SaveDocumentImage
       •    SaveProblemsData
       •    SaveTask
       •    SearchMeds




A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.   8
Go to Market Plans
 Provide information on business plans, including:
       • Genelex national sales team will coordinate with Allscripts field sales teams to
         leverage existing customer relationships and new prospects
       • Genelex will work with Allscripts to provide Webinar’s and seminars to educate
         Allscripts customers about the solution.
       • YouScript will be offered to Allscripts customers on a per user basis as an add-
         on service.
       • A 30-day free trial version will be available at Allscripts discretion.
       • Allscripts will receive a percentage of all per user fees.
       • Allscripts will receive a percentage of revenue for all tests generated through
         the ordering process. This is a significant revenue opportunity.
       • Initial target will be ambulatory physicians with particular emphasis on primary
         care, cardiology, pain, and psychiatry.
       • Targeting will expand to Hospitals and Medical Centers in stage 2.

A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.   9
Video Demonstration
 Video link: http://youtu.be/pw7fP71LeVs

 Description of what the demo shows
       • The demo shows the integration points between Allscripts and YouScript
         with a brief overview of how physicians can use YouScript to identify
         harmful interactions, prevent possible adverse drug events and lower
         their practice’s adverse drug event risk.




A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.   10
Why this solution should be selected!
 Despite widespread use of drug interaction software, one person dies every
     5 minutes from “properly” prescribed drugs.
 Current drug interaction software is only capable of predicting binary drug-
     drug interactions, overlooking over one-third of significant risks.
 YouScript is the only software available to predict drug-gene, multi-drug
     and cumulative interaction risks - and offer safer alternatives, making it the
     first real step towards putting personalized medicine into practice.
 Updated bi-weekly, the YouScript database and algorithm is the most
     comprehensive resource and predictor of possible interactions, encompassing:
       • Over 2500 drugs & metabolites
       • Herbals, Over-the-counters, foods, and patient factors
       • Over 14,000 PubMed links & notes curated by medical experts
 Empowering physicians with pharmacogenetic insights at the point of
     care helps physicians provide better care and improves patient outcomes.

A Connected Community of Health   | Copyright © 2011 Allscripts Healthcare Solutions, Inc.   11

More Related Content

What's hot

IMS Health Real-World Evidence Solutions at ISPOR November 2015
IMS Health Real-World Evidence Solutions at ISPOR November 2015IMS Health Real-World Evidence Solutions at ISPOR November 2015
IMS Health Real-World Evidence Solutions at ISPOR November 2015
IMSHealthRWES
 
6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP
CitiusTech
 
IMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data StudyIMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data Study
IMSHealthRWES
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient Access
PAREXEL International
 
Using Digital Innovation to Establish Authentic Reporter Dialogue
Using Digital Innovation to Establish Authentic Reporter DialogueUsing Digital Innovation to Establish Authentic Reporter Dialogue
Using Digital Innovation to Establish Authentic Reporter Dialogue
Sophia Ahrel FCIM
 
Understanding Risk Stratification, Comorbidities, and the Future of Healthcare
Understanding Risk Stratification, Comorbidities, and the Future of HealthcareUnderstanding Risk Stratification, Comorbidities, and the Future of Healthcare
Understanding Risk Stratification, Comorbidities, and the Future of Healthcare
Health Catalyst
 
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
MyMeds&Me
 
FICO Medication Adherence Score
FICO Medication Adherence ScoreFICO Medication Adherence Score
FICO Medication Adherence Score
GSW
 
The Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_finalThe Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_final
Billy Franks
 
Leveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk PatientsLeveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk Patients
CitiusTech
 
Quantitative signal detection for the mid sized pharma - webcast
Quantitative signal detection for the mid sized pharma - webcastQuantitative signal detection for the mid sized pharma - webcast
Quantitative signal detection for the mid sized pharma - webcast
pharmasol
 
Predictive Analytics Usage and Implications in Healthcare
Predictive Analytics Usage and Implications in HealthcarePredictive Analytics Usage and Implications in Healthcare
Predictive Analytics Usage and Implications in Healthcare
J. Bryan Bennett, MBA, CPA, LSSGB
 
The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...
The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...
The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...
Health Catalyst
 
Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...
Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...
Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...
Health Catalyst
 
1645 ainsworth
1645 ainsworth1645 ainsworth
1645 ainsworth
Rising Media, Inc.
 
Care Management Part 2 - A Critical Component of Effective Population Health
Care Management Part 2 - A Critical Component of Effective Population HealthCare Management Part 2 - A Critical Component of Effective Population Health
Care Management Part 2 - A Critical Component of Effective Population Health
Health Catalyst
 
Five Keys To Success In The New Patient Economy
Five Keys To Success In The New Patient EconomyFive Keys To Success In The New Patient Economy
Five Keys To Success In The New Patient Economy
RAPP
 
850 keynote savage_using his laptop
850 keynote savage_using his laptop850 keynote savage_using his laptop
850 keynote savage_using his laptop
Rising Media, Inc.
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
Hadas Jacoby
 
iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...
iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...
iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...
Health IT Conference – iHT2
 

What's hot (20)

IMS Health Real-World Evidence Solutions at ISPOR November 2015
IMS Health Real-World Evidence Solutions at ISPOR November 2015IMS Health Real-World Evidence Solutions at ISPOR November 2015
IMS Health Real-World Evidence Solutions at ISPOR November 2015
 
6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP6 Epilepsy Use Cases for NLP
6 Epilepsy Use Cases for NLP
 
IMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data StudyIMS Health Enriched Real-World Data Study
IMS Health Enriched Real-World Data Study
 
Generating Evidence to Drive Patient Access
Generating Evidence to Drive Patient AccessGenerating Evidence to Drive Patient Access
Generating Evidence to Drive Patient Access
 
Using Digital Innovation to Establish Authentic Reporter Dialogue
Using Digital Innovation to Establish Authentic Reporter DialogueUsing Digital Innovation to Establish Authentic Reporter Dialogue
Using Digital Innovation to Establish Authentic Reporter Dialogue
 
Understanding Risk Stratification, Comorbidities, and the Future of Healthcare
Understanding Risk Stratification, Comorbidities, and the Future of HealthcareUnderstanding Risk Stratification, Comorbidities, and the Future of Healthcare
Understanding Risk Stratification, Comorbidities, and the Future of Healthcare
 
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
Debating the Future of Spontaneous Reporting - Dr. Andrew Rut, CEO and Founde...
 
FICO Medication Adherence Score
FICO Medication Adherence ScoreFICO Medication Adherence Score
FICO Medication Adherence Score
 
The Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_finalThe Role of RWE in Drug Development_4Jun2015_final
The Role of RWE in Drug Development_4Jun2015_final
 
Leveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk PatientsLeveraging Analytics to Identify High Risk Patients
Leveraging Analytics to Identify High Risk Patients
 
Quantitative signal detection for the mid sized pharma - webcast
Quantitative signal detection for the mid sized pharma - webcastQuantitative signal detection for the mid sized pharma - webcast
Quantitative signal detection for the mid sized pharma - webcast
 
Predictive Analytics Usage and Implications in Healthcare
Predictive Analytics Usage and Implications in HealthcarePredictive Analytics Usage and Implications in Healthcare
Predictive Analytics Usage and Implications in Healthcare
 
The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...
The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...
The Healthcare Outcomes Improvement Engine: The Best Way to Ensure Sustainabl...
 
Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...
Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...
Use ACE Scores in Machine Learning to Predict Disease Earlier and Improve Out...
 
1645 ainsworth
1645 ainsworth1645 ainsworth
1645 ainsworth
 
Care Management Part 2 - A Critical Component of Effective Population Health
Care Management Part 2 - A Critical Component of Effective Population HealthCare Management Part 2 - A Critical Component of Effective Population Health
Care Management Part 2 - A Critical Component of Effective Population Health
 
Five Keys To Success In The New Patient Economy
Five Keys To Success In The New Patient EconomyFive Keys To Success In The New Patient Economy
Five Keys To Success In The New Patient Economy
 
850 keynote savage_using his laptop
850 keynote savage_using his laptop850 keynote savage_using his laptop
850 keynote savage_using his laptop
 
Big data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simpleBig data, RWE and AI in Clinical Trials made simple
Big data, RWE and AI in Clinical Trials made simple
 
iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...
iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...
iHT2 Health IT Summit Boston 2013 – Larry Garber, Medical Director, Reliant M...
 

Viewers also liked

EMUG 2013 Presentation
EMUG 2013 PresentationEMUG 2013 Presentation
EMUG 2013 Presentation
Brock Heinz
 
Электрический ток в полупроводниках
Электрический ток в полупроводникахЭлектрический ток в полупроводниках
Электрический ток в полупроводниках
boba100bars
 
PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE LAS TIC EN L...
PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE          LAS TIC EN L...PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE          LAS TIC EN L...
PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE LAS TIC EN L...
Marlyn Fuentes
 
Finalbigbazaarppt 110213123346-phpapp01
Finalbigbazaarppt 110213123346-phpapp01Finalbigbazaarppt 110213123346-phpapp01
Finalbigbazaarppt 110213123346-phpapp01
yaaali
 
Empower network your way to success
Empower network   your way to successEmpower network   your way to success
Empower network your way to success
Sibhi Bhaskar
 
Open app challenge_-_phase_1_submission_genelex_final
Open app challenge_-_phase_1_submission_genelex_finalOpen app challenge_-_phase_1_submission_genelex_final
Open app challenge_-_phase_1_submission_genelex_final
Genelex2013
 
Sbo solution detail
Sbo solution detailSbo solution detail
Sbo solution detail
Prakash Garimella
 
Mantras for success by Mithoon RV
Mantras for success by Mithoon RVMantras for success by Mithoon RV
Mantras for success by Mithoon RV
Mithoon RV
 
Medidata AMUG Meeting / Presentation 2013
Medidata AMUG Meeting / Presentation 2013Medidata AMUG Meeting / Presentation 2013
Medidata AMUG Meeting / Presentation 2013
Brock Heinz
 
La Gerencia y el Ciclo de vida de un proyecto
La Gerencia y el Ciclo de vida de un proyectoLa Gerencia y el Ciclo de vida de un proyecto
La Gerencia y el Ciclo de vida de un proyecto
Marlyn Fuentes
 
Bentuk geometri
Bentuk geometriBentuk geometri
Bentuk geometri
Akhmad Fathoni
 
Current economic scenario india
Current economic scenario indiaCurrent economic scenario india
Current economic scenario india
rsnlnt
 
Mobilink and Ufone Comparision - Marketing
Mobilink and Ufone Comparision - Marketing Mobilink and Ufone Comparision - Marketing
Mobilink and Ufone Comparision - Marketing
Fawad Samejo
 

Viewers also liked (15)

EMUG 2013 Presentation
EMUG 2013 PresentationEMUG 2013 Presentation
EMUG 2013 Presentation
 
Электрический ток в полупроводниках
Электрический ток в полупроводникахЭлектрический ток в полупроводниках
Электрический ток в полупроводниках
 
PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE LAS TIC EN L...
PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE          LAS TIC EN L...PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE          LAS TIC EN L...
PLANTEAMIENTO DE ESTRATEGIAS PARA EL APROVECHAMIENTO DE LAS TIC EN L...
 
Doc1
Doc1Doc1
Doc1
 
Finalbigbazaarppt 110213123346-phpapp01
Finalbigbazaarppt 110213123346-phpapp01Finalbigbazaarppt 110213123346-phpapp01
Finalbigbazaarppt 110213123346-phpapp01
 
Empower network your way to success
Empower network   your way to successEmpower network   your way to success
Empower network your way to success
 
Open app challenge_-_phase_1_submission_genelex_final
Open app challenge_-_phase_1_submission_genelex_finalOpen app challenge_-_phase_1_submission_genelex_final
Open app challenge_-_phase_1_submission_genelex_final
 
Sbo solution detail
Sbo solution detailSbo solution detail
Sbo solution detail
 
Mantras for success by Mithoon RV
Mantras for success by Mithoon RVMantras for success by Mithoon RV
Mantras for success by Mithoon RV
 
Medidata AMUG Meeting / Presentation 2013
Medidata AMUG Meeting / Presentation 2013Medidata AMUG Meeting / Presentation 2013
Medidata AMUG Meeting / Presentation 2013
 
Adverbs of-frequency k5
Adverbs of-frequency k5Adverbs of-frequency k5
Adverbs of-frequency k5
 
La Gerencia y el Ciclo de vida de un proyecto
La Gerencia y el Ciclo de vida de un proyectoLa Gerencia y el Ciclo de vida de un proyecto
La Gerencia y el Ciclo de vida de un proyecto
 
Bentuk geometri
Bentuk geometriBentuk geometri
Bentuk geometri
 
Current economic scenario india
Current economic scenario indiaCurrent economic scenario india
Current economic scenario india
 
Mobilink and Ufone Comparision - Marketing
Mobilink and Ufone Comparision - Marketing Mobilink and Ufone Comparision - Marketing
Mobilink and Ufone Comparision - Marketing
 

Similar to Open app challenge_-_phase_1_submission_genelex_final

Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Bhaswat Chakraborty
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
Priyesh Pandya
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
NEHA GUPTA
 
Trends in Early Development
Trends in Early DevelopmentTrends in Early Development
Trends in Early Development
PAREXEL International
 
BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11
William Tillman
 
iMPak Health Kraken Allscripts open app challenge
iMPak Health Kraken Allscripts open app challengeiMPak Health Kraken Allscripts open app challenge
iMPak Health Kraken Allscripts open app challenge
iMPak1
 
SampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App ChallengeSampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App Challenge
jakehalpert
 
Developing Drugs in the New Era of Personalized Medicines
Developing Drugs in the New Era of Personalized Medicines Developing Drugs in the New Era of Personalized Medicines
Developing Drugs in the New Era of Personalized Medicines
PAREXEL International
 
The High 5 S initiative
The High 5 S initiativeThe High 5 S initiative
The High 5 S initiative
Plan de Calidad para el SNS
 
Allscripts final phase1_232013
Allscripts final phase1_232013Allscripts final phase1_232013
Allscripts final phase1_232013
Elias Lozano
 
Diagnotes open app challenge - phase 1 submission
Diagnotes   open app challenge - phase 1 submissionDiagnotes   open app challenge - phase 1 submission
Diagnotes open app challenge - phase 1 submission
Diagnotes
 
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxPV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
SAMYUKTHAKANDULA
 
Allscripts Presentation
Allscripts PresentationAllscripts Presentation
Allscripts Presentation
Senior Wellness Solutions
 
Signifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management planSignifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management plan
Ansuman Parida
 
Fda guidance for post marketing study commitments professor pirouzi
Fda guidance for post marketing study commitments   professor pirouziFda guidance for post marketing study commitments   professor pirouzi
Fda guidance for post marketing study commitments professor pirouzi
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?
AppScript
 
EOP.SOJA.S5
EOP.SOJA.S5EOP.SOJA.S5
EOP.SOJA.S5
Rob Janknegt
 
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Ajaz Hussain
 
Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management
Dr. Ashish singh parihar
 
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLSDiscovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Katalyst HLS
 

Similar to Open app challenge_-_phase_1_submission_genelex_final (20)

Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...
 
Pharmacovigilance
PharmacovigilancePharmacovigilance
Pharmacovigilance
 
ICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdfICH Guidelines for Pharmacovigilance.pdf
ICH Guidelines for Pharmacovigilance.pdf
 
Trends in Early Development
Trends in Early DevelopmentTrends in Early Development
Trends in Early Development
 
BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11BioTech Medical Solutions - Pain RD short 8.5x11
BioTech Medical Solutions - Pain RD short 8.5x11
 
iMPak Health Kraken Allscripts open app challenge
iMPak Health Kraken Allscripts open app challengeiMPak Health Kraken Allscripts open app challenge
iMPak Health Kraken Allscripts open app challenge
 
SampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App ChallengeSampleRX: Allscripts Open App Challenge
SampleRX: Allscripts Open App Challenge
 
Developing Drugs in the New Era of Personalized Medicines
Developing Drugs in the New Era of Personalized Medicines Developing Drugs in the New Era of Personalized Medicines
Developing Drugs in the New Era of Personalized Medicines
 
The High 5 S initiative
The High 5 S initiativeThe High 5 S initiative
The High 5 S initiative
 
Allscripts final phase1_232013
Allscripts final phase1_232013Allscripts final phase1_232013
Allscripts final phase1_232013
 
Diagnotes open app challenge - phase 1 submission
Diagnotes   open app challenge - phase 1 submissionDiagnotes   open app challenge - phase 1 submission
Diagnotes open app challenge - phase 1 submission
 
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptxPV UTILISATION, APPLICATION WHO PROGRAMME.pptx
PV UTILISATION, APPLICATION WHO PROGRAMME.pptx
 
Allscripts Presentation
Allscripts PresentationAllscripts Presentation
Allscripts Presentation
 
Signifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management planSignifcance of pharmacovigilance & risk management plan
Signifcance of pharmacovigilance & risk management plan
 
Fda guidance for post marketing study commitments professor pirouzi
Fda guidance for post marketing study commitments   professor pirouziFda guidance for post marketing study commitments   professor pirouzi
Fda guidance for post marketing study commitments professor pirouzi
 
Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?Is mHealth Prescribing: Dead or Thriving?
Is mHealth Prescribing: Dead or Thriving?
 
EOP.SOJA.S5
EOP.SOJA.S5EOP.SOJA.S5
EOP.SOJA.S5
 
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
Complex Generics Developing Defensible Statistical Analyses and Acceptance Cr...
 
Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management Pharmacoepidemiology and risk management
Pharmacoepidemiology and risk management
 
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLSDiscovery of Drug and Introduction to Clinical Trial_Katalyst HLS
Discovery of Drug and Introduction to Clinical Trial_Katalyst HLS
 

Open app challenge_-_phase_1_submission_genelex_final

  • 1. YouScript Personalized Prescribing System from Genelex “Putting personalized medicine into practice” Kristine Ashcraft, COO, Genelex Copyright © 2011 Allscripts Healthcare Solutions, Inc. 1
  • 2. Solution Overview  YouScript® is the first and only clinical decision support tool that enables healthcare providers to consider cumulative multi-drug and gene interactions not covered by e-prescribing or EHR software interaction checking.  YouScript integration with Allscript EHRs enables providers to consider the pharmacogenetic risk associated with a patient’s drug regimen at the point of care and to predict and prevent adverse drug events. • Assesses each providers’ patients to highlight those at high-risk, indicate whether pharmacogenetic testing is suggested, and offer risk management options. • Once tested, the patient’s Personalized Prescribing Report and genotype will be added to the patient’s profile. • Continues to monitor changes to the provider’s patient set, alerting the provider to new risks, and reflecting the total interaction risk for the provider’s patient population.  YouScript helps reduce the practice’s overall ADE risk level and contributes to better outcomes.  YouScript is the first real step towards putting personalized medicine into practice. A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 2
  • 3. Solution Overview  Healthcare/Business problem addressed: • Adverse drug events are the third leading cause of death in the U.S. and cost the nation $289 billion in unnecessary healthcare costs. • More than 75% of the population have genetic variations that change how they react to the majority of commonly prescribed medicines. • YouScript helps reduce adverse drug events by ensuring every patient receives the right medication for their unique genotype in the context of their current medication regimen. Ultimately, this helps physicians improve patient outcomes and satisfaction, reduce ER visits and hospitalizations, and save time in medication selection.  The application developed addresses the following category:  Applications that improve management of high cost chronic diseases.  Innovative approaches to addressing value-based care imperatives.  Both A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 3
  • 4. Usability and Design  YouScript leverages the tasking feature of Allscripts EHRs to prompt the provider to review high- risk patients on their schedule and consider pharmacogenetic testing when appropriate.  Once tested, YouScript adds actionable alerts to the Provider’s task list requiring them to review and approve the patient’s personal prescribing report.  YouScript aligns with the Allscript’s physician’s daily workflow by monitoring patient records for medication changes and prompting the provider to take action whenever a patient is placed at significant risk.  YouScript’s actionable Interaction Reports allow the physician to explore implications of possible medication changes, and identify the safest alternatives for the patient prior to prescribing.  YouScript empowers the provider to manage their practice’s overall risk level by providing dashboard views summarizing total population risk, and making concrete recommendations for next steps. A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 4
  • 5. YouScript/Allscripts Workflow One Time 1 Test High 2 3 Review Test PGX Risk 4 Results Adjust Identify High Patients Risk Patients Medication Drug Risk Review Regimen Only YouScript Ongoing 5 6 7 Monitor Alert Provider Drug Change Change if Significant Impact A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc.
  • 6. Development Stage  Please indicate the development stage as of the Phase 1 Submission Date:  Idea  Prototype  Code development in progress  Code complete  Code complete, tested and approved by Allscripts. • UI design and development is complete. Allscripts integration development is 50% complete with code complete targeted at end of March for a May release date. A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 6
  • 7. Integration Description  Current implementation based on available Allscripts APIs include: • Patient Demographic Data for the provider to view through YouScript. • Patient Medication Lists are extracted into YouScript. • YouScript inserts tasks into the provider task list • YouScript inserts new documents as a lab result and attaches them to a task. • YouScript updates patient record with genotype test results  Proposed additional features requiring new Allscripts APIs: • Real-time alert of ADE risk increases when medication changes are made A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 7
  • 8. Integration Description  APIs/Web Services calls include: • GetPatient • GetPatientSections • GetSchedule • SearchPatient • SaveDocumentImage • SaveProblemsData • SaveTask • SearchMeds A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 8
  • 9. Go to Market Plans  Provide information on business plans, including: • Genelex national sales team will coordinate with Allscripts field sales teams to leverage existing customer relationships and new prospects • Genelex will work with Allscripts to provide Webinar’s and seminars to educate Allscripts customers about the solution. • YouScript will be offered to Allscripts customers on a per user basis as an add- on service. • A 30-day free trial version will be available at Allscripts discretion. • Allscripts will receive a percentage of all per user fees. • Allscripts will receive a percentage of revenue for all tests generated through the ordering process. This is a significant revenue opportunity. • Initial target will be ambulatory physicians with particular emphasis on primary care, cardiology, pain, and psychiatry. • Targeting will expand to Hospitals and Medical Centers in stage 2. A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 9
  • 10. Video Demonstration  Video link: http://youtu.be/pw7fP71LeVs  Description of what the demo shows • The demo shows the integration points between Allscripts and YouScript with a brief overview of how physicians can use YouScript to identify harmful interactions, prevent possible adverse drug events and lower their practice’s adverse drug event risk. A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 10
  • 11. Why this solution should be selected!  Despite widespread use of drug interaction software, one person dies every 5 minutes from “properly” prescribed drugs.  Current drug interaction software is only capable of predicting binary drug- drug interactions, overlooking over one-third of significant risks.  YouScript is the only software available to predict drug-gene, multi-drug and cumulative interaction risks - and offer safer alternatives, making it the first real step towards putting personalized medicine into practice.  Updated bi-weekly, the YouScript database and algorithm is the most comprehensive resource and predictor of possible interactions, encompassing: • Over 2500 drugs & metabolites • Herbals, Over-the-counters, foods, and patient factors • Over 14,000 PubMed links & notes curated by medical experts  Empowering physicians with pharmacogenetic insights at the point of care helps physicians provide better care and improves patient outcomes. A Connected Community of Health | Copyright © 2011 Allscripts Healthcare Solutions, Inc. 11